Log in
Create new account
home
boards
job center
archives
company monitor
cp wire
device news
pharmagather
advertise
contact us
Home
vitreomacular adhesion
ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A
ThromboGenics Bid Seen on Eye Drug Treatment: Real M&A
Bloomberg
Jetrea
M&A
ThromboGenics
vitreomacular adhesion
With FDA panel nod, ThromboGenics closer to first potential drug
With FDA panel nod, ThromboGenics closer to first potential drug
Fierce Biotech
FDA
ocriplasmin
ThromboGenics
vitreomacular adhesion
news tags
Abbott Laboratories
Amgen
Arena Pharmaceuticals
AstraZeneca
Bayer
Biogen Idec
biotech
Boston Scientific
Bristol-Myers Squibb
cancer
Celgene
China
Dendreon
diabetes
earnings
Eli Lilly
Europe
FDA
generics
Genzyme
GSK
hepatitis C
investors
JNJ
lawsuits
layoffs
M&A
Management
Medtronic
Merck
Novartis
obesity
patents
Pfizer
prostate cancer
Roche
Sanofi
Teva Pharmaceuticals
vaccines
Vivus
more tags
Yahoo! Finance
Quote for ABT